AbbVie (ABBV) stock forecast for 2022. Forecast tables and graphs.

AbbVie (ABBV) stock forecast for 2022

The forecast has been updated: July 28, 2021 7:24


AbbVie stock price online today

Analyst Target Price

124.08

Dividend Date

16.08.2021

Ex Dividend Date

14.07.2021

Last Split Factor

None

Last Split Date

-

Should you buy or sell AbbVie stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? AbbVie stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $124.08 target price for AbbVie stock stock.

Today 200 Day Moving Average is the support level (110.8 $).

50 Day Moving Average is the support level (115.41 $).




ABBV Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 113.93 111.02 120.49 7.87 %
Feb 112.29 107.89 117.23 7.97 %
Mar 109.06 103.21 110.80 6.85 %
Apr 107.14 103.71 113.05 8.26 %
May 106.80 104.83 108.59 3.46 %
Jun 105.26 100.46 111.66 10.03 %
Jul 106.35 103.54 111.37 7.03 %
Aug 109.16 104.27 112.30 7.15 %
Sep 114.31 111.20 116.42 4.48 %
Oct 122.73 120.47 124.98 3.61 %
Nov 124.00 117.55 125.99 6.69 %
Dec 122.41 119.18 126.23 5.59 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of AbbVie stock.


AbbVie overview

AbbVie Address

1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US

Market Capitalization

208 007 725 000 $

EBITDA

24 527 000 000

PE Ratio

40.43

PEG Ratio

1.279

Dividend Per Share

4.96

Dividend Yield

0.0421

EPS

2.913

Quarterly Earnings Growth YOY

-0.015

Quarterly Revenue Growth YOY

0.509

Trailing PE

40.43

Forward PE

9.5

EV To Revenue

5.67

EV To EBITDA

19.2

52 Week High

118.67

52 Week Low

77.49

50 Day Moving Average

115.41

200 Day Moving Average

110.8

Shares Outstanding

1766220000

Shares Float

1740789000

Shares Short Prior Month

13342600

Short Ratio

2.49

Percent Insiders

0.125

Percent Institutions

69.04

AbbVie stock forecast for this year


AbbVie stock forecast for Jan 2022.
Estimated Average Forecasted AbbVie Price: 113.93. Negative monthly dynamics of the instrument is expected with 7.867% volatility is expected.

Pessimistic forecast: 111.02

Optimistic: 120.49


AbbVie stock forecast for Feb 2022.
Estimated Average Forecasted AbbVie Price: 112.29. Negative monthly dynamics of the instrument is expected with 7.970% volatility is expected.

Pessimistic forecast: 107.89

Optimistic: 117.23


AbbVie stock forecast for Mar 2022.
Estimated Average Forecasted AbbVie Price: 109.06. Negative monthly dynamics of the instrument is expected with 6.850% volatility is expected.

Pessimistic forecast: 103.21

Optimistic: 110.80


AbbVie stock forecast for Apr 2022.
Estimated Average Forecasted AbbVie Price: 107.14. Negative monthly dynamics of the instrument is expected with 8.264% volatility is expected.

Pessimistic forecast: 103.71

Optimistic: 113.05


AbbVie stock forecast for May 2022.
Estimated Average Forecasted AbbVie Price: 106.80. Negative monthly dynamics of the instrument is expected with 3.462% volatility is expected.

Pessimistic forecast: 104.83

Optimistic: 108.59


AbbVie stock forecast for Jun 2022.
Estimated Average Forecasted AbbVie Price: 105.26. Negative monthly dynamics of the instrument is expected with 10.031% volatility is expected.

Pessimistic forecast: 100.46

Optimistic: 111.66


AbbVie stock forecast for Jul 2022.
Estimated Average Forecasted AbbVie Price: 106.35. Positive monthly dynamics of the instrument is expected with 7.028% volatility is expected.

Pessimistic forecast: 103.54

Optimistic: 111.37


AbbVie stock forecast for Aug 2022.
Estimated Average Forecasted AbbVie Price: 109.16. Positive monthly dynamics of the instrument is expected with 7.154% volatility is expected.

Pessimistic forecast: 104.27

Optimistic: 112.30


AbbVie stock forecast for Sep 2022.
Estimated Average Forecasted AbbVie Price: 114.31. Positive monthly dynamics of the instrument is expected with 4.478% volatility is expected.

Pessimistic forecast: 111.20

Optimistic: 116.42


AbbVie stock forecast for Oct 2022.
Estimated Average Forecasted AbbVie Price: 122.73. Positive monthly dynamics of the instrument is expected with 3.613% volatility is expected.

Pessimistic forecast: 120.47

Optimistic: 124.98


AbbVie stock forecast for Nov 2022.
Estimated Average Forecasted AbbVie Price: 124.00. Positive monthly dynamics of the instrument is expected with 6.693% volatility is expected.

Pessimistic forecast: 117.55

Optimistic: 125.99


AbbVie stock forecast for Dec 2022.
Estimated Average Forecasted AbbVie Price: 122.41. Negative monthly dynamics of the instrument is expected with 5.586% volatility is expected.

Pessimistic forecast: 119.18

Optimistic: 126.23



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 121.09 (29.07.2021) 0.47 %
AbbVie Inc.
ABBV 118.87 (29.07.2021) 0.27 %
Aeterna Zentaris Inc.
AEZS 0.7254 (29.07.2021) -6.38 %
Allakos Inc.
ALLK 81.5 (29.07.2021) -0.40 %
Allogene Therapeutics, Inc.
ALLO 22.37 (29.07.2021) -0.89 %
Amgen Inc.
AMGN 242.46 (29.07.2021) -0.73 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 13.05 (29.07.2021) -1.06 %
Aurora Cannabis Inc.
ACB 7.11 (29.07.2021) -2.47 %
Becton Dickinson and Company
BDX 255.31 (29.07.2021) 0.72 %
Biogen Inc.
BIIB 329.17 (29.07.2021) -1.50 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 126.14 (29.07.2021) -0.96 %
BioNTech SE
BNTX 312.59 (29.07.2021) -0.27 %
bluebird bio, Inc.
BLUE 25.66 (29.07.2021) -1.31 %
Boston Scientific Corp.
BSX 45.32 (29.07.2021) -0.24 %
Bristol-Myers Squibb Company
BMY 68.15 (29.07.2021) -0.84 %
Canopy Growth Corp.
CGC 19.54 (29.07.2021) -0.31 %
Castle Biosciences, Inc.
CSTL 68.51 (29.07.2021) -0.20 %
Eli Lilly and Company
LLY 245.33 (29.07.2021) -0.48 %
Emergent BioSolutions Inc.
EBS 65.22 (29.07.2021) 0.09 %
Exelixis, Inc.
EXEL 16.86 (29.07.2021) -1.63 %
G1 Therapeutics, Inc.
GTHX 17.38 (29.07.2021) -3.82 %
Gilead Sciences, Inc.
GILD 69.83 (29.07.2021) -0.33 %
GlaxoSmithKline plc
GSK 40.1 (29.07.2021) 1.52 %
GoodRx Holdings, Inc.
GDRX 32.52 (29.07.2021) -0.91 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.4 (29.07.2021) -0.78 %
Inovio Pharmaceuticals, Inc.
INO 8.5 (29.07.2021) -1.96 %
Johnson & Johnson
JNJ 172.18 (29.07.2021) 0.00 %
Medtronic plc.
MDT 130.68 (29.07.2021) 0.12 %
Merck & Co., Inc.
MRK 76.93 (29.07.2021) -1.79 %
Moderna, Inc.
MRNA 345.64 (29.07.2021) -1.05 %
Novartis AG
NVS 92.19 (29.07.2021) 0.33 %
Novavax, Inc.
NVAX 184 (29.07.2021) -2.65 %
ObsEva SA
OBSV 2.59 (29.07.2021) -1.52 %
OrganiGram Holdings Inc.
OGI 2.65 (29.07.2021) -2.93 %
Pfizer Inc.
PFE 42.79 (29.07.2021) -1.52 %
Regeneron Pharmaceuticals, Inc.
REGN 583.13 (29.07.2021) -0.56 %
Sanofi
SNY 51.53 (29.07.2021) -1.02 %
Schrodinger, Inc.
SDGR 68.33 (29.07.2021) -2.55 %
Senseonics Holdings, Inc.
SENS 3.05 (29.07.2021) -0.97 %
Sorrento Therapeutics, Inc.
SRNE 8.39 (29.07.2021) -2.21 %
Stryker Corp.
SYK 269.18 (29.07.2021) 0.19 %
Sundial Growers Inc.
SNDL 0.823 (29.07.2021) -3.18 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.69 (29.07.2021) -3.00 %
Thermo Fisher Scientific Inc.
TMO 533.77 (29.07.2021) 1.04 %
Tilray, Inc.
TLRY 15.42 (29.07.2021) -3.69 %
UnitedHealth Group, Inc.
UNH 412.08 (29.07.2021) 0.71 %
Veeva Systems Inc.
VEEV 332.61 (29.07.2021) 0.15 %
Zomedica Corp.
ZOM 0.61 (29.07.2021) -4.42 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.53 (29.07.2021) -3.62 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.